# BioLineRx (BLRX) — News

BLRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/blrx/news

## Recent headlines

- [Biolinerx Q2 revenue USD 294 thousand](https://www.ainvest.com/news/biolinerx-q2-revenue-usd-294-thousand-2608) — AInvest Wire, Aug 31, 2026
- [Biolinerx Q2 net income USD -4.3 million](https://www.ainvest.com/news/biolinerx-q2-net-income-usd-4-3-million-2608) — AInvest Wire, Aug 31, 2026
- [Biolinerx reports $3.75M registered direct offer, placement](https://www.ainvest.com/news/biolinerx-reports-3-75m-registered-direct-offer-placement-2608) — AInvest Wire, Aug 28, 2026
- BioLineRx shares climb 22% after FDA approves Aphexda with filgrastim — AInvest Wire, Sep 11, 2023
- **Important** — BioLineRx Gets FDA Approval for Aphexda With Filgrastim — AInvest Wire, Sep 11, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).